# Pharmacokinetics, Safety and Efficacy of HR020602 Injection in Children Undergoing General Anesthesia

> **NCT04867343** · PHASE2 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 70 (actual)

## Conditions studied

- Used to Induce and Implement General Anesthesia in Combination With Sedative Anesthetics (Such as Propofol)

## Interventions

- **DRUG:** HR020602 injection
- **DRUG:** fentanyl injection ； remifentanil injection

## Key facts

- **NCT ID:** NCT04867343
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-07
- **Primary completion:** 2023-08-15
- **Final completion:** 2023-08-15
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04867343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04867343, "Pharmacokinetics, Safety and Efficacy of HR020602 Injection in Children Undergoing General Anesthesia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04867343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*